156 related articles for article (PubMed ID: 34048180)
1. Combination Therapy of TRAIL and Thymoquinone Induce Breast Cancer Cell Cytotoxicity-Mediated Apoptosis and Cell Cycle Arrest.
Abdel Salam NM; Abd-Rabou AA; Sharada HM; El Samea GGA; Abdalla MS
Asian Pac J Cancer Prev; 2021 May; 22(5):1513-1521. PubMed ID: 34048180
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis.
Abd-Rabou AA; Abd El-Salam NM; Sharada HMI; Abd El Samea GG; Abdalla MS
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2855-2865. PubMed ID: 34582654
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines.
Teng JW; Hung E; Wu JM; Liang YH; Chiu YH; Tyan YS; Wang HS
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1297-1305. PubMed ID: 37116152
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression.
El-Far AH; Saddiq AA; Mohamed SA; Almaghrabi OA; Mousa SA
Integr Cancer Ther; 2022; 21():15347354221099537. PubMed ID: 35583244
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer.
Bhattacharjee M; Upadhyay P; Sarker S; Basu A; Das S; Ghosh A; Ghosh S; Adhikary A
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129695. PubMed ID: 32735937
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage.
Zhang R; Wu T; Zheng P; Liu M; Xu G; Xi M; Yu J
DNA Repair (Amst); 2021 Jul; 103():103117. PubMed ID: 33990030
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of death receptor 5 is responsible for increased cytotoxicity of theophylline in combination with recombinant human TRAIL in MDA-MB-231 breast cancer cells.
Tapadar P; Pal A; Dutta S; Pal R
J Cancer Res Ther; 2022; 18(3):754-759. PubMed ID: 35900550
[TBL] [Abstract][Full Text] [Related]
13. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine.
Wong SHM; Fang CM; Loh HS; Ngai SC
Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels.
Kisim A; Atmaca H; Cakar B; Karabulut B; Sezgin C; Uzunoglu S; Uslu R; Karaca B
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1155-63. PubMed ID: 22411600
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells.
Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA
Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
17. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
[TBL] [Abstract][Full Text] [Related]
18. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells.
Al-Mutairi A; Rahman A; Rao MS
Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice.
Odeh LH; Talib WH; Basheti IA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S324-S330. PubMed ID: 29970684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]